Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

hexion australia pty ltd - formaldehyde - liquid - formaldehyde - aldehyde - active - 400.0 - g/l - disinfectant

Bangladesh - English - DGDA (Directorate General of Drug Administration)

orion pharma ltd. - chlorhexidine gluconate + isopropyl alcohol - solution - 500 mg + 70 gm/100 ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advanced feeds pty ltd - bromhexine hydrochloride; trimethoprim; sulfadimidine - oral powder, pre-mix - bromhexine hydrochloride guanidine active 9.0 mg/g; trimethoprim pyrimidine active 90.0 mg/g; sulfadimidine sulfanyl active 450.0 mg/g - antibiotic & related - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - actinobacillus equuli | escherichia coli (e. coli) | infections of the respiratory tract | pasteurella spp. | salmonella | staphylococcus aureus | staphylococcus intermedius | streptococcus equi var equi | streptococcus zooepidemicus | acute respiratory infections | bronchiseptica | bronchitis | deep pyodermas | including b-lactamase producin | including secondary invaders | pasterellosis | pasteurellosis | pharyngitis | pneumonia | salmonellosis | seborrhoeic dermatitis | tonsillitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - bromhexine hydrochloride; trimethoprim; sulfadimidine - oral powder, pre-mix - bromhexine hydrochloride guanidine active 8.6 mg/g; trimethoprim pyrimidine active 86.0 mg/g; sulfadimidine sulfanyl active 430.0 mg/g - respiratory + antibiotic - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - bacterial infection | infections of the respiratory tract | respiratory disease | acute respiratory infections | amoxycillin sensitive bacteria | associated with viral disease | bronchiseptica | bronchitis | gram negative organisms | gram positive organisms | pharyngitis | pneumonia | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | tonsillitis | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 0.8 mg/ml - oral liquid - excipient ingredients: benzoic acid; maltitol solution; menthol; purified water; sucralose; flavour - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 1.6 mg/ml - oral liquid - excipient ingredients: menthol; purified water; benzoic acid; sucralose; maltitol solution; flavour - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 8 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride, quantity: 0.8 mg/ml - oral liquid - excipient ingredients: maltitol solution; hyetellose; benzoic acid; sucralose; purified water; flavour - for use as a mucolytic to break down mucus and help clear the chest in conditions accompanied by excessive mucus secretions, such as in the common cold, influenza, infections of the respiratory tract or in other conditions where excess mucus is produced.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - bromhexine hydrochloride, quantity: 0.8 mg/ml; salbutamol sulfate, quantity: 0.482 mg/ml - oral liquid - excipient ingredients: sodium benzoate; hyetellose; citric acid; menthol; propylene glycol; sucralose; purified water; flavour

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - bromhexine hydrochloride, quantity: 1.6 mg/ml - oral liquid - excipient ingredients: sodium benzoate; saccharin sodium; sodium citrate dihydrate; propylene glycol; xanthan gum; citric acid; sorbitol solution (70 per cent) (non-crystallising); glycerol; purified water; flavour - as a mucolytic - breaks down mucus and helps clear stubborn chest congestion.